OxiAge – a new database for reversible protein thiol oxidation in aged cells.  Read the publication in Life Science Alliance: https://doi.org/10.26508/lsa.202302300

Today, IMol joins the global community in recognizing Rare Disease Day. We appreciate the importance of awareness about the challenges faced by individuals with rare diseases. Our research aims to develop treatments for mitochondrial diseases.

We are happy to announce that Dr. Justyna Zmorzynska, IMol Group Leader, has been awarded the NCN SONATA BIS grant! Justyna will study how factors related to maternal infection during pregnancy influence the developing brain. She is particularly interested in how these environmental factors change the neuronal connections and brain function in autism spectrum disorder. […]

Join our next edition of IMol Science Club with Prof. Salvador Aznar Benitah from the Institute for Research in Biomedicine (IRB Barcelona). Salvador holds a BSc/MSc in Biochemistry from the McGill University (Montreal, Canada) and PhD in Molecular Biology from the Biomedical Research Institute (Madrid, Spain). During his postdoctoral fellowship at the London Research Institute […]

We have a few openings for postdoc positions. Join us to work in the topics of: Go to https://www.imol.institute/career-lab to find out who we are looking for and spread the news.

Congratulations to Dr. Anna Marusiak on receiving her habilitation degree! The Scientific Council at IBB PAS formally confirmed Anna’s academic degree as a “habilitated doctor” on 30th January 2024, granted with distinction. Anna’s scientific work contributed to the discovery of the oncogenic functions of MLK kinases and their role in driving resistance to cancer treatments.